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Background: Pseudomonas aeruginosa is the most common bacterial pathogen infecting the lungs of patients with
cystic fibrosis (CF). The Liverpool Epidemic Strain (LES) is transmissible, capable of superseding other P. aeruginosa
populations and is associated with increased morbidity. Previously, multiple inducible prophages have been found
to coexist in the LES chromosome and to constitute a major component of the accessory genome not found in
other sequenced P. aerugionosa strains. LES phages confer a competitive advantage in a rat model of chronic
lung infection and may, therefore underpin LES prevalence. Here the infective properties of three LES phages
were characterised.
Results: This study focuses on three of the five active prophages (LESφ2, LESφ3 and LESφ4) that are members of
the Siphoviridae. All were induced from LESB58 by norfloxacin. Lytic production of LESφ2 was considerably higher
than that of LESφ3 and LESφ4. Each phage was capable of both lytic and lysogenic infection of the susceptible
P. aeruginosa host, PAO1, producing phage-specific plaque morphologies. In the PAO1 host background, the LESφ2
prophage conferred immunity against LESφ3 infection and reduced susceptibility to LESφ4 infection. Each
prophage was less stable in the PAO1 chromosome with substantially higher rates of spontaneous phage
production than when residing in the native LESB58 host. We show that LES phages are capable of horizontal gene
transfer by infecting P. aeruginosa strains from different sources and that type IV pili are required for infection by all
three phages.
Conclusions: Multiple inducible prophages with diverse infection properties have been maintained in the LES
genome. Our data suggest that LESφ2 is more sensitive to induction into the lytic cycle or has a more efficient
replicative cycle than the other LES phages.
Keywords: Pseudomonas aeruginosa, Prophage induction, Bacteriophage infection, Cystic fibrosis, Host range,
Type IV piliBackground
Pseudomonas aeruginosa is a versatile Gram-negative
bacterium, able to metabolise multiple carbon sources
and exploit diverse ecological niches, e.g. soil, water,
plants and animal hosts [1,2]. This opportunistic patho-
gen causes a range of human infections, including acute
infections of severe wounds [3] and burns [4,5] and* Correspondence: cejames@liv.ac.uk
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reproduction in any medium, provided the orchronic lung infections in cystic fibrosis (CF) patients
[6]. P. aeruginosa forms biofilms in the CF lung that are
highly resistant to antibiotics and clearance by the im-
mune system [7]. Once established, such biofilms cannot
be eradicated and are associated with greatly increased
morbidity and mortality [8].
Several CF-associated transmissible strains of P.
aeruginosa, capable of between patient transmission,
have been identified in the UK, Europe, Australia and
North America [9]. The Liverpool Epidemic Strain
(LES), a UK transmissible strain, was first isolated intd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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pool [10]. This strain is capable of super-infection, sup-
planting pre-existing P. aeruginosa populations in the
CF lung [11]. Chronic infection with LES is associated
with increased morbidity and mortality compared to
other P. aeruginosa strains [12]. The LES is highly preva-
lent within individual hospital CF units [13] and is the
most abundant P. aeruginosa strain amongst CF patients
in the UK [14]. It was also recently isolated from the
sputa of CF patients in North America [15].
Sequencing of the earliest LES isolate, LESB58,
demonstrated that the genome shares 95% similarity
with the lab strain PAO1. However, its core genome is
punctuated by multiple norfloxacin-inducible prophages
[16]. Specifically, there are five inducible prophage gen-
omes (LESφ2; LESφ3 LESφ4 LESφ5 and LESφ6) that are
mosaic in nature. The gene organisation of LESφ2 and
LESφ3 resembles that of lambdoid phages. These two
phage genomes share 82.2% identity across a 13.6-kb
region at their 3’ ends that makes up 32% of the phage
genomes. The closest known relative to both these
phages is the Pseudomonas phage F10 [17]. LESφ3 also
contains a 7.5 kb region that shares 99.8% homology
with LESφ5, which exhibits a considerable sequence
similarity to the O-antigen converting phage D3 [18].
LESφ4 is a transposable Mu-like phage that closelyFigure 1 Exposure to sub-inhibitory concentrations of norfloxacin ind
LESB58 cultures (OD600 0.5) were exposed to sub-inhibitory norfloxacin (50
extraction. Total phage vs prophage numbers were quantified by Q-PCR w
levels of each phage over time; A: LESφ2; B: LESφ3; C: LESφ4. ■+norfloxac
deducting prophage numbers from total phage numbers. The average free
is shown. Three independent experimental repeats were performed, each wresembles phage D3112 [19]. The LESφ6 sequence
resembles a pf1-like filamentous phage [16].
Temperate phages have been shown to confer select-
ive, beneficial traits to a range of P. aeruginosa hosts
[20]. For example, phage D3 orchestrates O antigen con-
version from O5 to O16 in PAO1, which may aid eva-
sion of the immune system and resistance to phage
superinfection [18,21]. Phage φCTX infection of PAS10
results in conversion to a toxigenic strain [22] and the
filamentous phage, Pf1, has been associated with biofilm
disruption and dispersal [23]. LES prophages have been
suggested to contribute to the competitiveness of their
bacterial host in vivo. LESB58 mutants, with disrupted
prophage genes, exhibited 10 to 1000-fold decreased
competitiveness in a rat model of chronic lung infection
compared to wild type LESB58 [16]. The LES phages are
induced by exposure to clinically relevant antibiotics, e.g.
ciprofloxacin [24], and free LES phages and other tailed-
phage virions have been detected in CF patient sputa
[25,26].
Temperate phages are key vectors of horizontal gene
transfer (HGT) [27]. Therefore, it is important to assess
the ability of the LES phages to infect other bacterial
hosts to which they may confer traits beneficial to life in
the CF lung environment. Here we describe the infection
characteristics of three of the five LES prophages LESφ2,uces the lytic cycle of three LES phages. Mid-exponential phase
ug ml-1) for 30 and 60 min before recovery for 2 h and total DNA
ith SYBR green and specific primers. Graphs show the production
in; □ – norfloxacin. D: Quantities of free phage were calculated by
phage numbers at each time interval were plotted and Standard error
ith 3 technical repeats.
Figure 2 PCR confirmation of all PAO1 LES phage lysogens.
Lysogens were isolated from turbid plaques following sequential
infection of PAO1 with pure stocks of each LES phage. Lysogens
were considered resistant if no plaques were observed following
exposure to increasingly high titre phage suspensions (up to MOI
100). The presence of each prophage was confirmed using multiplex
PCR with specific primer sets for each LES phage yielding
differentially sized products: 325 bp (LESφ3); 250 bp (LESφ2); 100 bp
(LES φ 4).
Table 1 Differential Immunity profiles of each LES phage
in PAO1
Efficiency of plating values φ2 φ3 φ4
PAO1 naive host 1.0 1.0 1.0
Single φ2 lysogen < 1x10 -9 < 1x10 -9 0.017
Single φ3 lysogen 0.91 < 1x10 -9 0.37
Single φ4 lysogen 1.09 0.94 3.3x10 -9
Immunity profiles of each LES phage were determined by plaque assay. Phage
dilution series were spotted onto non-Lysogenic PAO1 and PLPL lawns.
Efficiency of plating = the ratio of plaques observed (at the appropriate phage
dilution) on the most permissive host (non-lysogenic PAO1)/plaques observed
on assay host (PLPL harbouring LESφ2, LESφ3 or LESφ4 prophages). If no
plaques were observed when neat phage suspensions of 1010 p.f.u ml-1 were
used, an eop value < 1x10-9 was recorded.
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isolate LESB58.
Results
LES phage morphology
Three different Siphoviridae phages were induced
from LESB58 cultures and visualised using electron mi-
croscopy. The phages possessed icosahedral heads
(50–60 nm diameter) and long flexible tails (approxi-
mately 200 nm). Plaque assay of each phage on PAO1
resulted in the formation of small turbid plaques with
different phage-specific morphologies. LESφ3 plaques
were the largest (2–3 mm), with well-defined lysogen
islands, whereas LESφ2 plaques were considerably
smaller (0.5-1.5 mm). LESφ4 produced plaques with
small, clear centres surrounded by a turbid halo. The
identity of each LES phage responsible for the different
plaque morphologies was confirmed using a multiplex
PCR assay.
Differential induction of LES phages from LESB58
The sensitivity of the LES phages to induction into the
lytic cycle was determined and compared. Real-time
quantitative (Q)-PCR was used to measure relative
increases in phage DNA copy number following induc-
tion by exposure of LESB58 to norfloxacin. After
exposure to norfloxacin for 60 min and recovery for 2 h,
LESφ2 was the most abundant free phage detected
(6.2 x 107 copies μl-1), compared to LESφ3 (6.9 x 106
copies μl-1) and LESφ4 (1 x 107 copies μl-1) (Figure 1).
Furthermore, the increase in LESφ2 production between
30 and 60 min exposure times was higher (3.67 fold in-
crease) than that for LESφ3 (1.74 fold increase) and
LESφ4 (2.06 fold increase). Thus while norfloxacin in-
duction caused a significant increase in the replication of
all three phages (LESφ2 - F1, 8 56.97, P 0.001; LESφ3 - F1,
8 14.02, P 0.006; LESφ4 - F1, 8 16.88, P 0.003), only LESφ2
showed significantly greater phage production after
60 min compared to 30 min norfloxacin exposure (induc-
tion*time interaction, F1, 8 20.90, P 0.002); by contrast,
the duration of exposure had no effect on phage produc-
tion in LESφ3 and LESφ4 (induction*time interaction,
LESφ3 - F1, 8 1.05, P 0.336; LESφ4 - F1, 8 3.19, P 0.112).
We suggest therefore that LESφ2 is either more sensitive
to induction by norfloxacin or that it replicates more
rapidly once induced.
Lysogenic infection of a model PAO1 host
PAO1 LES phage lysogens (PLPLs) were created by in-
fection of strain PAO1 with each LES phage and isola-
tion of single colonies from turbid areas within plaques
(Figure 2). Challenge of PLPLs with different LES
phages, using plaque assays, revealed varying immunity
profiles. Table 1 lists the efficiency of plating (eop)values of each LES phage on each PLPL lawn. Prophages
2 and 3 conferred immunity to super-infection by LESφ2
and LESφ3 respectively (eop < 1 x10-9). However, a few
LESφ4 super-infection events were observed by detec-
tion of plaques following exposure of lysogens to 1 x
1010 p.f.u ml-1 of LESφ4 (eop = 3.33 x 10-9). LESφ2 was
able to infect PLPLs harbouring prophages LESφ3 (eop
0.91) and LESφ4 (eop 1.09) at the same efficiency as
non-lysogenic PAO1. However, lysogens harbouring the
LESφ2 prophage were resistant to infection by LESφ3
(eop < 1x10-9) and showed considerably reduced suscep-
tibility to LESφ4 (eop 0.017).
Spontaneous phage production by all seven PLPLs was
higher than that associated with LESB58, by 5–6 orders
of magnitude (P < 0.05) (Figure 3). These data suggest
that LES prophages are less stable in PAO1, with signifi-
cantly higher rates of spontaneous lytic phage produc-
tion than in LESB58. Little difference was observed in
Figure 3 Spontaneous lysis exhibited by LES phages in PAO1 vs LESB58. Phage production was quantified from filtered culture
supernatants of un-induced mid-exponential phase cultures using standard plaque assay. Standard deviation is shown (n = 3).
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single, double and triple PAO1 lysogens.LES phages integrate at the same sites in different
bacterial host strains
Southern blot analysis was used to demonstrate that
lysogenic instability was not due to integration of the
LES phages into unstable sites of the naive PAO1
chromosome, or from multiple integration events of the
same phage (Figure 4). LESφ2 and LESφ3 integrated as
single copies at identical locations in LESB58 and PAO1
chromosomes.
The LESφ2 int probe hybridised to an additional DNA
fragment in all lysogens containing LESφ2, including
LESB58. The size of the additional hybridised fragment
corresponds to one of two possibilities: 1) the integration
of a second LESφ2 copy in to the chromosome directly
downstream of the first; 2) an extra copy of LESφ2 in
circular form (Figure 4). The published LESB58 genome
sequence clearly shows a single LESφ2 copy in the
chromosome. Since the hybridisation pattern of the
PAO1 LESφ2 lysogen matches that of LESB58, a second
chromosomal copy can be ruled out. This suggests that
the extra copy is circular, which may represent phage
replication resulting from spontaneous activation of the
lytic life cycle. Alternatively, the extra copy may indicate
pseudolysogeny, in which stable circular copies are
maintained.
The LESφ4 cI probe indicated that LESφ4 is able to
integrate in several chromosomal locations in PAO1.LES phages infect a narrow host range in a type IV
pilus-dependant manner
From a well-characterised panel of 32 clinical P.
aeruginosa isolates, 6 were susceptible to LES phage in-
fection. Of 25 environmental isolates, representing 17
different Pseudomonas species, only the P. aeruginosa
strain was susceptible. In addition, PA14 was resistant to
infection by LESφ2 and LESφ3, but susceptible to
LESφ4. Plaques on PA14 appeared less turbid than those
on PAO1 lawns. The host ranges of each LES phage
were not identical and no correlation was found between
bacterial clone-type [28] and susceptibility (data not
shown). In addition, other common Gram-negative CF
pathogens Burkholderia cenocepacia and B. multivorans
strains were resistant to infection by all three LES
phages (Table 2).
A non-piliated PAO1 mutant (pilA-) was resistant to
infection by all 3 phages, suggesting that LESφ2, 3 and 4
all require type IV pili for infection. The hyper-piliated
mutant (pilT-) was also resistant to the LES phages,
whilst an alternative hyper-piliated mutant (pilU-)
remained fully susceptible.
Discussion
Differential induction among co-infecting prophages
Induction experiments demonstrated that LESφ2 virions
were produced from LESB58 in greater numbers than
the other phages. These data suggest that LESφ2 replica-
tion is more efficient than the other phages and could
out number and therefore out compete the other, co-
infecting LES phages during the lytic cycle. Potentially
Figure 4 Southern analysis of LES phage integration sites in
LESB58 and PAO1. Southern blot analysis to determine LES phage
copies and integration sites in LESB58 and PLPL chromosomes: A)
PstI digested LES phage lysogens hybridised to LESφ2 integrase (int)
probe; B) DraIII digested LES phage lysogens hybridised to LESφ3
integrase probe; C) AcuI digested LES phage lysogens hybridised to
LESφ4 cI probe. A diagrammatical representation of the restriction
pattern is presented below each blot. This demonstrates the
expected size of fragments that would hybridise each probe in the
event of single phage integration (one band) or integration of two
identical prophages in tandem (two bands). For clarity, the second
phage copy has been shaded in grey. The 2-band pattern would also
result if any additional phage copies were present in circular form.
Table 2 Susceptibility of a panel of Pseudomonas isolates
to LES phages 2, 3 and 4
Isolate source (#) φ2 φ3 φ4
Reference strains (2) 50% (1/2) 50% (1/2) 100% (2/2)
Keratitis patient (12) 8.3% (1/12) 0% (0/12) 33.3% (4/12)
Non-LES child (8) 12.5% (1/8) 0% (0/8) 12.5% (1/8)
Non-LES adult (6) 16.7% (1/6) 0% (0/6) 0% (0/6)
Anomalous LES (6) 0% (0/6) 0% (0/6) 0% (0/6)
Environmental (25) 0% (0/25) 4% (1/25) 0% (0/25)
Percentage of LES phage-sensitive strains as determined by plaque assay.
Actual numbers tested are shown in parentheses.
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this phage in the LESφ2 lysogen genome. Southern ana-
lysis suggests the presence of either a pseudo-lysogenicplasmid form [29], or a highly active replicative form of
LESφ2 during spontaneous phage production.
The implications of within-host competition between
co-infecting prophages has been little studied, however
Refardt et al. [30] observed hierarchical competition be-
tween multiple prophages in E. coli, which suggested
that the sensitivity of the lytic switch can determine
dominance of one prophage over another in a polylyso-
gen. Carriage of phages that are very prone to activation
of the lytic lifecycle may represent a significant cost to
their host cells, and thus could be selected against in
natural populations. However, while natural isolates of
LES sampled from CF patient sputa often lack one or
more of the LES prophages [25], there is no evidence
that LESφ2 is more or less stably maintained than
LESφ3 or LESφ4.
LES phages exhibit different immunity profiles
Each phage conferred inhibition of superinfection by the
same phage, although the Mu-like phage, LESφ4 was
observed to infect LESφ4 lysogens at a very low fre-
quency. This may represent the development of rare
mutations that affect immunity functions. There are sev-
eral examples of such mutations in phage Mu [31].
Repressor/operator coevolution has been suggested to
be the driving force for the evolution of superinfection
immunity groups of lambdoid phages [32]. The same
may hold true for Mu-like phages. For example, muta-
tion of the operator region has been shown to affect
binding of the repressor in Mu vir mutants [33].
Sequential infection of PAO1 with different LES
phages revealed an interesting superinfection hierarchy.
LESφ3 lysogens remained susceptible to LESφ2 and
LESφ4; and LESφ4 lysogens were susceptible to LESφ2
and LESφ3. However, LESφ2 prevented infection by
LESφ3 and greatly reduced susceptibility to LESφ4. Such
uni-directional infection exclusion has been reported be-
tween other phages, and is commonly associated with
super-infection exclusion genes such as the lambda rex
genes [34] and sieA, sieB and a1 in the Salmonella
phage, P22 [35-38].
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have been acquired before LESφ2, because the infection
hierarchy suggests that prior acquisition of LESφ2 would
have prevented subsequent LESφ3 and LESφ4 infection.
LES prophages in PAO1 undergo spontaneous activation
to the lytic cycle at a far higher rate than in LESB58
High levels of spontaneous induction were observed in
PLPLs, suggesting that lysogeny is relatively unstable in
the PAOl genetic background. We show that phage pro-
duction remained high between PLPLs containing one,
two or three LES prophages, suggesting that polylyso-
gens were no more or less stable than any single lyso-
gens. Southern analysis confirmed that LESφ2 and
LESφ3 integrated into the same position in PLPLs as
they did in LESB58. Therefore, the instability of PLPLs
was not due to prophage integration into unstable sites.
LESφ4 integrated in several alternative sites in PLPLs.
The sequence of this phage shares a high level of
genome synteny and homology with the transposable
Mu-like phage D3112 [16], whose random integration
has been demonstrated to create mutations within the
host chromosome. LESφ4 may play a similar role in LES
genome evolution.
The LES phages exhibit a narrow host-range
Our investigation of the LES phage host range revealed
narrow, overlapping host specificity. No association
between bacterial clone-type and phage susceptibility
was observed, although testing more strains may have
identified a pattern. Despite the high proportion of
resistant clinical isolates, our data show that LES phages
are capable of infecting some P. aeruginosa strains
isolated from keratitis patients and non-LES infected CF
patients. LES phages have been detected in CF patients’
sputa, and may therefore allow mobilisation of genes
between P. aeruginosa strains [25,26]. By contrast, LES
phages may allow LES to displace other P. aeruginosa
strains during superinfection in the CF lung [11] by
lysing susceptible resident strains [39].
LES phage infection is Type IV pilus-dependent
We demonstrate that LES phage infection is dependent
on the type IV pilus, which is required by P. aeruginosa
for adhesion, biofilm formation and twitching motility
[40-42]. This important surface structure is commonly
used as a receptor by diverse Pseudomonas phages [43].
Both non-piliated (pilA-) and hyper-piliated (pilT-) PAO1
mutants were resistant to infection by all three LES
phages. However, a different hyper-piliated mutant (pilU-)
remained susceptible. These findings mirror other
pilin-dependent P. aeruginosa phage studies [43-45].
Hyper-piliated mutants are incapable of twitching motility
due to abrogated pili retraction. These data suggest thatretraction is involved in the infection process by LESφ2
LESφ3 and LESφ4.
Despite infecting via an important and common sur-
face structure, all three LES phages exhibited narrow
host ranges and each showed strain specificities. For
example, LESφ4 was able to infect PA14 and several
keratitis isolates that were resistant to infection by the
other LES phages. It is likely that many clinical strains
of P. aeruginosa harbour prophages that may belong to
the same immunity group and therefore exclude super-
infection by one or more of the LES phages [20].
Alternatively, resistance could be achieved by loss or
modification of the type IV pili receptor [44,45].
Conclusion
In summary, we demonstrate that the LES phages
exhibit differential sensitivities to induction, narrow host
ranges and divergent infection behaviour in the model
host PAO1 compared with the native LESB58 host back-
ground. Extensive genotypic and phenotypic variation
has been observed in clinical LES populations [46],
including changes in the number of resident LES
prophages [25]. These phages may, therefore, be import-
ant contributors to diversity of the LES populations.
Methods
Bacterial strains and growth conditions
All bacterial strains used in this study and their sources
are listed in Table 3. LES phages were induced from the
sequenced CF P. aeruginosa isolate, LESB58 [16]. Strain
PAO1 was susceptible to infection by all three LES
phages and was therefore used as a model host to pur-
ify and study the characteristics of each phage. Succes-
sive infection of PAO1 with purified LES phages yielded
single, double and triple PAO1 LES Phage Lysogens
(PLPLs) each harbouring single copies of one, two or
three LES phages simultaneously. All lysogens were
confirmed by PCR amplification of specific prophage
sequences and Southern blot analysis. Non-piliated
(pilA-) or hyperpiliated (pilT- and pilU-) PAO1 mutants
[47] were used to determine whether LES phages infect
via the type IV pili. All bacterial strains and phages
were grown and propagated in standard lysogeny broth
(LB) at 37°C (clinical isolates) or 23°C (environmental
isolates). Phage suspensions were stored in LB at 4°C.
Bacteriophage induction
P. aeruginosa LESB58 was grown to mid-exponential
phase (OD600 0.5) and LES phages were induced into the
lytic cycle by exposure to the minimum inhibitory con-
centration of norfloxacin (50 μg ml-1) for 1 h [24].
Induced cultures were sub-cultured (1:10) into fresh LB
to enable recovery for 2 h before filtration (0.2 μm Milli-
pore). Active phage particles in the induced supernatants
Table 3 Bacterial strains and sources
Strain (1Clone type) Reference/
source
Laboratory P. aeruginosa strains:
PAO1(W) [2]
PAO1 pilA-; PAO1 pilU-; PAO1 pilT-2 [47]
PA14(A) [48]
Clinical LES isolates:
LESB 58 (T) - Sequenced isolate [16]
LES 431 (T) - Lacks LES prophage 2 [49]
Anomalous LES isolates3:
O69574 (T); 0521 (T); 43513 (T);
079444 (T); 0342 (T).
[50]
P. aeruginosa isolates from keratitis patients4:
39015 (B); 39115 (A); 39103 (A2);
39145 (A3); 39053 (A5); 39135 (C);
39016 (D); 39421 (F); 39061 (I);
39284 (L); 39376 (U); 39129 (V).
[51]
P. aeruginosa isolates from non-LES infected CF patients:
CHILDREN: AH23 (B); AH4 (A);
AH19 (A3); AH14 (C); AH1 (D);
AH6 (L); AH9 (U); AH7 (A4);
AHCH5
ADULTS: NL28 (A); NL20 (C);
NL25 (F); NL16 (U); NL21 (A4);
NL14 (A7).
RLUH6
Environmental Pseudomonas spp: Strain
P. aeruginosa 159 RJ7
P. fluorescens WC5365; F113;
ATCC 17400;
pf5; pf01.
P. syringae ‘tomato’ DC300;
B728a
P. syringae pv. Coriandricola Ccola
P. syringae pv. maculocola M4
P. syringae pv. antirrhini 152E
P. putida KT2440;
Paw340
P. cichori 907
P. avellanae 48
P. phaseiolicola 1448A
P. entomophila L48
P. marginalis 247
P. corrugata 2445
P. tolaasii 2192 T
P. glycinea 49a/90
P. lachrymans 789
P. agarici 2472
P. viridiflava 2848
Table 3 Bacterial strains and sources (Continued)
B. cenocepacia K56-2; J2315. [52]
B. multivorans F-A1-1;
LMG 13010.
1Clones typed using the Clondiag tube array system [51]; 2 PAO1 pil mutants
acquired from Angus Buckling, University of Exeter. 3Isolates classified as
anomalous following negative diagnostic PCR result for one of two specific
target sequences, but identified as LES using the tube array system. These
isolates were also missing one or more LES prophage. 4 Strains isolated from
Keratitis patients from several hospitals across the UK. 5 AHCH: Isolates
collected from child CF patients attending the Alder-Hey Children’s Hospital,
Liverpool. 6 RLUH: Isolates collected from adult CF patients attending the
Royal Liverpool University Hospital. 7 RJ -Environmental isolates of several
Pseudomonas species donated by R Jackson, University of Reading.
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host cells.
Bacteriophage assays
LES phages were isolated from induced LESB58 cul-
tures using plaque assays with PAO1 host cultures as
described previously [24]. Phages were purified by pick-
ing individual plaques that were suspended in LB
(1 ml), filter sterilized (0.2 μm Millipore) and used in a
second plaque assay with PAO1. This process was
repeated twice to ensure purity. Phage purity was con-
firmed using PCR assays. Amplification of phage stocks
was achieved by modifying previous methods [53].
Briefly, mid-exponential phase PAO1 cultures (100 ml)
were infected with purified LES phage (MOI = 0.1), at
37°C for 2 h. Lysed cultures were filter-sterilized.
Electron microscopy
Phage suspensions (1x109 – 1x1010 p.f.u. ml-1) were con-
centrated by centrifugation, negatively stained with 2%
(w/v) uranyl acetate [54], and examined by transmission
electron microscopy (magnification x 200,000).
Multiplex PCR to confirm pure phage stocks and lysogens
Three primer sets, LESnest1 F/R, Clust6nest F/R and
4tot1 F/R (Table 4), for the detection of LES phages 2, 3
and 4 respectively, were combined in a multiplex PCR
assay for confirmation of each pure phage stock and each
PLPL. Colony or filtered phage suspensions were used as
templates in each reaction as described previously [25].
Quantifying production of each LES phage from LESB58
Replication of each LES phage in response to induction
of the lytic cycle was compared using Q-PCR to distin-
guish and enumerate each specific phage type. LESB58
induction experiments were performed on three separate
occasions in the presence and absence of norfloxacin for
30 and 60 min exposure times before the 2 h recovery
step. DNA was prepared from each replicate using the
Bacterial and Virus DNA extraction kit (QIAGEN) and
the automated QIAsymphony machine (QIAGEN;
Table 4 Primer sequences
Primer Sequence (50-30) Amplicon (bp) Cycling conditions Reference
Multiplex PCR:
LES1nestF tttggtgatgatcggcttagc 289 95°C, 4 min then 30 cycles:
95°C, 30 s; 58°C, 30 s; 72°C, 30 s;
final extension step, 72°C, 7 min;
[25]
LES1nestR tgtggaagcgatcagtct
Clust6nestF ggatcgacgtggcataatctg 410 [25]
Clust6nestR acgattctccggcatgcagcg
4tot1F gctcatgagtggctgacaac 105 This study
4tot1R tcttgggcagagaaccattc
Q-PCR:
2pro3F caagccctgtctggattttc 102 95°C, 10 min; then 40 cycles:
95°C, 10 s; 60°C, 15 s; 72°C s.
This study
2pro3R gagacaggttgggagggagt
3tot1F cgcaggtaccaccagacttt 122 This study
3tot1R catgtccagcaggttcaaaa
3pro3F gcggatgttctcaaacgaat 134 This study
3pro3R cgggagaagcaatgacctac
4tot1F gctcatgagtggctgacaac 105 This study
4tot1R tcttgggcagagaaccattc
4pro3F tcgtgctgtgctgatctttt 172 This study
4pro3R agcagtgccagttgatgttg
Preparation of DIG-labeled probes:
φ2intDIGF tgcctatctaacggggttca 1097 95°C, 4 min. 30 cycles:
95°C, 30 s; 55°C, 30 s; 72°C, 1 min s;
final extension step, 72°C, 7 min
This study
φ2intDIGR gaagcaaccgagaagtggag
φ3intDIGF ggatcatgtagcgggaaaga 874 This study
φ3intDIGR agaacctggcgaaagtctga
φ4cIDIGF atcgttaattggcacggaat 893 This study
φ4cIDIGR acagcaacggatttccactc
tot= to quantify total phage copies; pro= to quantify total phage copies.
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using six specific primer sets to differentiate between
prophage and total copies of each phage.
Real-time Q-PCR
Q-PCR was used to quantify LES phages by comparing
the number of specific amplicon copies in extracted
DNA from induction experiments to a concentration
gradient of known standards. Primer sets with the pre-
fixes, “tot” (total) and “pro” (prophage) were designed to
amplify unique regions within, and flanking, each LES
phage genome (Figure 1D). All primer sequences and
amplification details are listed in Table 4. Amplicon copy
number μl-1 was calculated using the formula [(6.023 x
1023 x [DNA] g/ml)/(molecular weight of product)]/
1,000 [55]. Molecular weight was calculated as number
of base pairs x 6.58 x 102 g. A 10-fold dilution series of
each DNA standard was prepared for quantification of
phage numbers in each sample.
Q-PCR reactions (25 ul) contained 1 uM each
primer pair and 1X Rotorgene-SYBR green supermix(QIAGEN). Phage numbers were quantified from DNA
samples (1 μl) in triplicate using a Rotorgene cycler
(QIAGEN). Q-PCR data were analyzed using Rotorgene
Q series software 1.7 (QIAGEN). Total phage and pro-
phage numbers from each sample were quantified in
separate reactions using “tot” and “pro” primer sets for
each phage and comparing fluorescent signals to those
from standard concentration gradients. The level of free
phage in a given sample was calculated by subtracting
prophage numbers from total phage numbers.Statistical analysis
Specific phage sequences were quantified in triplicate
from each of 3 experimental replicates using Q-PCR,
and technical replicates were averaged prior to analyses.
Differences in phage numbers, with and without nor-
floxacin and between time-points were analysed using
separate ANOVAs for each phage, fitting induction (2
levels), time (2 levels) and their interaction as fixed
factors.
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PAO1 LES phage lysogens (PLPLs) were isolated from
turbid islands in the centre of well-separated plaques
using a sterile toothpick and streaked on to Columbia
agar (Oxoid) to obtain single colonies. Individual lysogen
colonies were analysed by multiplex PCR assays to con-
firm the presence of LES prophages.
Immunity assays
Lawns of PAO1 and each PLPL were created by adding
mid-exponential phase (OD600 0.5) cultures (100 ul) to
molten 0.4% (v/v) agar and pouring onto Columbia agar
plates to set. A 10-fold dilution series of each purified
phage suspension (1010 – 103 p.f.u ml-1) was spotted
(20 ul) onto lawns of each host. Countable plaques were
observed at varying dilutions depending on the phage-
host combination. The efficiency of plating (eop) value
was calculated as the ratio of assay titre/most permissive
titre. The most permissive titre was obtained on non-
lysogenic PAO1.
Southern blot analysis
Southern analysis was performed as previously described
[56]. Specific probes were prepared using the digoxi-
genin (DIG) PCR labelling kit (Roche). DIG-labelled
probes were designed to hybridize targets within either
the LESφ2 int gene, the LESφ3 int gene, or the LESφ4
cI gene using primers: φ2intDIG F/R; φ3intDIG F/R
and φ4cIDIG F/R (Table 4). Bacterial genomic DNA
was extracted using a Wizard Genomic DNA extraction
kit (Promega) and digested using PstI, AcuI or DraIII
(NEB) according to the manufacturer’s instructions.
Probes were hybridised to digested genomic DNA as
described previously [53]. Hybridized probe was
detected using alkaline phosphatase-conjugated anti-
DIG antibody (1:10,000) and CPDstar substrate (1:100)
(Roche) according to the manufacturer’s instructions.
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